Adenosine Therapeutics, LLC
Records under this name other than the patents Adenosine Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Adenosine Therapeutics, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,598,379 | Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines Formerly held In force · High confidence | In force | High confidence | |
| US 7,605,143 | 2-Propynyl Adenosine Analogs with Modifed 5'-Ribose Groups Having A2A Agonist Activity Formerly held In force · High confidence | In force | High confidence | |
| US 7,342,006 | Substituted 8-Heteroaryl Xanthines Formerly held Term ended Term ended Nov 7, 2025 · High confidence | Term ended | Term ended Nov 7, 2025 | High confidence |
| US 8,420,813 | Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines Formerly held Lapsed on the fee record Ended Apr 16, 2025 · High confidence | Lapsed on the fee record | Ended Apr 16, 2025 | High confidence |
| US 7,732,455 | Substituted 8-Heteroaryl Xanthines Formerly held Term ended Term ended Aug 20, 2024 · High confidence | Term ended | Term ended Aug 20, 2024 | High confidence |
| US 8,188,063 | Use of Adenosine A2A Modulators to Treat Spinal Cord Injury Formerly held Lapsed on the fee record Ended May 29, 2024 · High confidence | Lapsed on the fee record | Ended May 29, 2024 | High confidence |
| US 8,178,509 | Method to Treat Sickle Cell Disease Formerly held Lapsed on the fee record Ended May 15, 2024 · High confidence | Lapsed on the fee record | Ended May 15, 2024 | High confidence |
| US 7,884,100 | Substituted 8-[6-Amino-3-Pyridyl]XANTHINES Formerly held Lapsed on the fee record Ended Feb 8, 2023 · High confidence | Lapsed on the fee record | Ended Feb 8, 2023 | High confidence |
| US 8,551,972 | Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth Lapsed on the fee record Ended Oct 8, 2021 · High confidence | Lapsed on the fee record | Ended Oct 8, 2021 | High confidence |
| US 9,555,129 | Adenosine derivative formulations for medical imaging Lapsed on the fee record Ended Jan 31, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 31, 2021 | From the USPTO record |